Insulin receptor substrate (IRS)-1 and IRS-2 are the major substrates that mediate insulin action. Insulin itself regulates the expression of the IRS protein in the liver, but the underlying mechanisms of IRS-1 and IRS-2 regulation are not fully understood. Here we report that insulin suppressed the expression of both IRS-1 and IRS-2 proteins in Fao hepatoma cells. The decrease in IRS-1 protein occurred via proteasomal degradation without any change in IRS-1 mRNA, whereas the insulin-induced suppression of IRS-2 protein was associated with a parallel decrease in IRS-2 mRNA without changing IRS-2 mRNA half-life. The insulin-induced suppression of IRS-2 mRNA and protein was blocked by the phosphatidylinositol (PI) 3-kinase inhibitor, LY294002, but not by the MAP kinase-ERK kinase (MEK) inhibitor, PD098059. Inhibition of Akt by overexpression of dominant-negative Akt also caused complete attenuation of the insulin-induced decrease in IRS-2 protein and partial attenuation of its mRNA down-regulation. Some nuclear proteins bound to the insulin response element (IRE) sequence on the IRS-2 gene in an insulin-dependent manner in vitro, and the binding was also blocked by the PI 3-kinase inhibitor. Reporter gene assay showed that insulin suppressed the activity of both human and rat IRS-2 gene promoters through the IRE in a PI 3-kinase-dependent manner. Our results indicate that insulin regulates IRS-1 and IRS-2 through different mechanisms and that insulin represses IRS-2 gene expression via a PI 3-kinase/Akt pathway.

This article has been cited by other articles:

				Y. Fujiwara, M. Hiroyama, A. Sanbe, T. Aoyagi, J.-i. Birumachi, J. Yamauchi, G. Tsujimoto, and A. Tanoue Insulin hypersensitivity in mice lacking the V1b vasopressin receptor J. Physiol., October 1, 2007; 584(1): 235 - 244. [Abstract] [Full Text] [PDF]

				A. Erhuma, A. M. Salter, D. V. Sculley, S. C. Langley-Evans, and A. J. Bennett Prenatal exposure to a low-protein diet programs disordered regulation of lipid metabolism in the aging rat Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1702 - E1714. [Abstract] [Full Text] [PDF]

				C. M. Taniguchi, J. O. Aleman, K. Ueki, J. Luo, T. Asano, H. Kaneto, G. Stephanopoulos, L. C. Cantley, and C. R. Kahn The p85{alpha} Regulatory Subunit of Phosphoinositide 3-Kinase Potentiates c-Jun N-Terminal Kinase-Mediated Insulin Resistance Mol. Cell. Biol., April 15, 2007; 27(8): 2830 - 2840. [Abstract] [Full Text] [PDF]

				D. Huang, M. Khoe, M. Befekadu, S. Chung, Y. Takata, D. Ilic, and M. Bryer-Ash Focal adhesion kinase mediates cell survival via NF-{kappa}B and ERK signaling pathways Am J Physiol Cell Physiol, April 1, 2007; 292(4): C1339 - C1352. [Abstract] [Full Text] [PDF]

				A. V. Matveyenko and P. C. Butler {beta}-Cell Deficit Due to Increased Apoptosis in the Human Islet Amyloid Polypeptide Transgenic (HIP) Rat Recapitulates the Metabolic Defects Present in Type 2 Diabetes. Diabetes, July 1, 2006; 55(7): 2106 - 2114. [Abstract] [Full Text] [PDF]

				C.-Y. Lin, T. Gurlo, L. Haataja, W. A. Hsueh, and P. C. Butler Activation of Peroxisome Proliferator-Activated Receptor-{gamma} by Rosiglitazone Protects Human Islet Cells against Human Islet Amyloid Polypeptide Toxicity by a Phosphatidylinositol 3'-Kinase-Dependent Pathway J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6678 - 6686. [Abstract] [Full Text] [PDF]

				B. Kim, C. M. van Golen, and E. L. Feldman Insulin-Like Growth Factor I Induces Preferential Degradation of Insulin Receptor Substrate-2 through the Phosphatidylinositol 3-Kinase Pathway in Human Neuroblastoma Cells Endocrinology, December 1, 2005; 146(12): 5350 - 5357. [Abstract] [Full Text] [PDF]

				F. Renstrom, J. Buren, and J. W. Eriksson Insulin Receptor Substrates-1 and -2 Are Both Depleted but via Different Mechanisms after Down-Regulation of Glucose Transport in Rat Adipocytes Endocrinology, July 1, 2005; 146(7): 3044 - 3051. [Abstract] [Full Text] [PDF]

				M. Fujimoto, N. Shimizu, K. Kunii, J.A. J. Martyn, K. Ueki, and M. Kaneki A Role for iNOS in Fasting Hyperglycemia and Impaired Insulin Signaling in the Liver of Obese Diabetic Mice Diabetes, May 1, 2005; 54(5): 1340 - 1348. [Abstract] [Full Text] [PDF]

				H. Sugita, M. Fujimoto, T. Yasukawa, N. Shimizu, M. Sugita, S. Yasuhara, J. A. J. Martyn, and M. Kaneki Inducible Nitric-oxide Synthase and NO Donor Induce Insulin Receptor Substrate-1 Degradation in Skeletal Muscle Cells J. Biol. Chem., April 8, 2005; 280(14): 14203 - 14211. [Abstract] [Full Text] [PDF]

				J. M. Schattenberg, Y. Wang, R. Singh, R. M. Rigoli, and M. J. Czaja Hepatocyte CYP2E1 Overexpression and Steatohepatitis Lead to Impaired Hepatic Insulin Signaling J. Biol. Chem., March 18, 2005; 280(11): 9887 - 9894. [Abstract] [Full Text] [PDF]

				K. Ueki, T. Kondo, and C. R. Kahn Suppressor of Cytokine Signaling 1 (SOCS-1) and SOCS-3 Cause Insulin Resistance through Inhibition of Tyrosine Phosphorylation of Insulin Receptor Substrate Proteins by Discrete Mechanisms Mol. Cell. Biol., June 15, 2004; 24(12): 5434 - 5446. [Abstract] [Full Text] [PDF]